Impact of a Gene Mutation on 5-FU Clearance in Cancer Treatment
Author Information
Author(s): Maring J G, van Kuilenburg A B P, Haasjes J, Piersma H, Groen H J M, Uges D R A, Van Gennip A H, De Vries E G E
Primary Institution: Diaconessen Hospital, Academic Medical Center, University of Amsterdam, Martini Hospital, University Hospital Groningen
Hypothesis
Does a mutation in the DPYD gene affect the clearance of 5-fluorouracil in patients?
Conclusion
The study found that a mutation in the DPYD gene significantly reduces the clearance of 5-fluorouracil, leading to severe toxicity in the patient.
Supporting Evidence
- The index patient had a significantly lower 5-FU clearance compared to control patients.
- The patient's DPD activity was lower than that of the control group.
- Sequence analysis revealed a heterozygous mutation in the DPYD gene.
- 5-FU is primarily metabolized by DPD, and reduced activity can lead to toxicity.
- About 2-3% of the population may have low DPD activity, increasing their risk for severe toxicity.
- Pharmacokinetic modeling indicated that renal function had a limited effect on 5-FU clearance.
- Monitoring 5-FU plasma levels can help identify patients at risk for toxicity.
Takeaway
A patient with a specific gene mutation had a hard time processing a cancer drug, which made them very sick. This shows that some people might need special tests before taking certain medicines.
Methodology
The study compared pharmacokinetics and DPD activity between one patient with severe toxicity and six control patients using blood samples and genetic analysis.
Potential Biases
The control patients were not matched for age and gender, which could introduce bias.
Limitations
DPD activity was measured at least 2 months after chemotherapy, which may not accurately reflect the patient's condition during treatment.
Participant Demographics
The index patient was a 60-year-old white female with Dukes C colorectal cancer.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website